3/26/2020
Neurofilament Light Chain: A Potential ALS Biomarker?

Biomarkers are an important part of medical research and drug development. A biomarker is a broad term that describes some sort of measurable property of the body, especially one that can tell us something about a disease. Common examples are glucose levels for type one diabetes and blood pressure for hypertension.

 

Today on Endpoints, ALS TDI CEO Dr. Steve Perrin joins us to talk about  what a biomarker is, how they’re used in drug research, and a promising possible biomarker for ALS and other neurodegenerative diseases: Neurofilament Light Chain.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} Biomarkers are an important part of medical research and drug development. A biomarker is a broad term that describes some sort of measurable property of the body, especially one that can tell us something about a disease. Common examples are glucose levels for type one diabetes and blood pressure for hypertension.   Today on Endpoints, ALS TDI CEO Dr. Steve Perrin joins us to talk about  what a biomarker is, how they’re used in drug research, and a promising possible biomarker for ALS and other neurodegenerative diseases: Neurofilament Light Chain.
Thank you to our Sponsors
Cytokinetics
Biogen
MT Pharma America
Apellis
Insource Services, Inc
Novartis
Regeneron
Ionis